Start of a new year

January 6, 2023

We have started the new year with welcoming Mr. Alex Gruman into the Business development director role. Alex will share his 35+ years experience in pharma business where he served different CDMOs as managing director as well as his long period within Rhone Poulenc...

Atracurium

December 1, 2022

Due to the Covid-pandemic a large volume of Atracurium was needed worldwide. Government agencies and private companies ordered huge amounts from the API. Atracurium is a muscle-relaxant mostly used for respiratory infections during the anesthesia procedure. It was a...

GMP Certificate for CF Pharma Ltd.

November 15, 2022

Successful renewal of the GMP Certificate for CF Pharma Ltd. Three members from the National Institute of Pharmacy (Hungarian: Országos Gyógyszerészeti Intézet, known as: „OGYI”) audited our companies for GMP compliance on 5 APIs (Atracurium besylate, Cabergoline,...

CPHI Worldwide in Frankfurt

November 1, 2022

Our company was represented on the CPHI Worldwide in Frankfurt. This was the first major pharmaceutical global event after the Covid pandemic, which was held live. It was a great pleasure to meet with new clients and discuss current and future business...

Hungarian Business Leaders Forum

October 10, 2022

Company CEO, Zita Schneider became a proud member of the Hungarian Business Leaders Forum (HBLF), and she attended their event as a member of Patriapharma...

R&D director

June 7, 2022

Imre Kovács now became the R&D director of our company. He will be leading the R&D-team, where he will oversee new synthesis, new technologies and CDMO production. CF Pharma now possesses 3...

Your Choices Regarding Cookies on this Site

Some functionality on this site requires your consent for cookies to work properly.

We use cookies to enhance your visit. By clicking Agree and Proceed you accept our use of cookies. You can also click on More Information to see detailed descriptions of the types of cookies and choose whether to accept certain cookies while on the site.